{"result": "\n{\n    \"title\": \"Cisatracurium and the ROSE Trial\",\n    \"summary\": \"The community centers around the use of Cisatracurium in the ROSE trial, which investigates its effects on patients with Acute Respiratory Distress Syndrome (ARDS). Key entities include various statistical tests and scoring systems used to evaluate the trial's outcomes, as well as the European Epidemiologic Study that provided essential data for the trial's design.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the potential implications of Cisatracurium's use in critical care settings and its associated mortality risk.\",\n    \"findings\": [\n        {\n            \"summary\": \"Cisatracurium's role in the ROSE trial\",\n            \"explanation\": \"Cisatracurium is a neuromuscular blocking agent used in the ROSE trial to assess its impact on 90-day mortality in ARDS patients. The trial compared Cisatracurium to a placebo group, aiming to improve survival rates and reduce barotrauma. However, there was one death possibly related to its use, highlighting the need for careful evaluation of its benefits and risks [Data: Entities (89); Relationships (273, 376, 382)].\"\n        },\n        {\n            \"summary\": \"Statistical methods employed in the trial\",\n            \"explanation\": \"The trial utilized several statistical tests to analyze data, including the Chi-square test, Student's t-test, and Wilcoxon's rank-sum test. These tests were crucial in comparing baseline variables and assessing differences between the Cisatracurium and placebo groups, ensuring robust analysis of the trial's outcomes [Data: Entities (94, 92, 540); Relationships (379, 377, 378, 416, 418)].\"\n        },\n        {\n            \"summary\": \"European Epidemiologic Study's contribution\",\n            \"explanation\": \"The European Epidemiologic Study played a significant role by providing data for the sample-size calculation in the multicenter trial. This data was essential for designing the trial and ensuring its statistical power, thereby contributing to the reliability of the trial's findings [Data: Entities (96); Relationships (423, 374)].\"\n        },\n        {\n            \"summary\": \"Use of scoring systems in patient assessment\",\n            \"explanation\": \"The Simplified Acute Physiology Score (SAPS) II and the Sequential Organ Failure Assessment (SOFA) score were used to assess the severity of illness in patients. These scoring systems helped healthcare professionals make informed decisions regarding patient care and evaluate the effect of Cisatracurium on 90-day mortality [Data: Entities (90, 624); Relationships (375, 385)].\"\n        },\n        {\n            \"summary\": \"Trial sites and international standards\",\n            \"explanation\": \"Cisatracurium was administered in 20 multidisciplinary ICUs following international standards of care. This widespread implementation across various trial sites underscores the importance of the trial's findings in potentially influencing global critical care practices [Data: Entities (210); Relationships (308, 384)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n89,CISATRACURIUM,\"Cisatracurium is a neuromuscular blocking agent used in the ROSE trial as part of the intervention group for patients with Acute Respiratory Distress Syndrome (ARDS). The study aimed to evaluate the effect of Cisatracurium on 90-day mortality in patients, comparing its use to a placebo group. It is administered as an early continuous infusion in ARDS patients to improve survival rates and reduce barotrauma. However, there was one death in the trial that was possibly related to the use of Cisatracurium.\",13\n96,EUROPEAN EPIDEMIOLOGIC STUDY,The EUROPEAN EPIDEMIOLOGIC STUDY is a research initiative that provided crucial data for the sample-size calculation in a trial.,2\n94,CHI-SQUARE TEST,The Chi-square test is a statistical test used to determine if there is a significant association between two categorical variables in a study. It is employed to compare categorical variables between two groups and to assess interactions between study groups and interventions.,4\n92,STUDENT'S T-TEST,Student's t-test is a statistical test used in the study to compare the means of two groups. It is specifically employed to compare baseline variables and assess differences between the two groups at the baseline stage.,4\n88,ACUTE LUNG INJURY VERIFICATION (ALIVE),The Acute Lung Injury Verification (ALIVE) is a European epidemiologic study that provides data for assumptions in sample-size calculations for clinical trials.,2\n90,SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) II,\"The Simplified Acute Physiology Score (SAPS) II is a scoring system designed to assess the severity of a patient's condition in intensive care units. It is calculated from 12 physiological measurements, previous health status, and admission information, with scores ranging from 0 to 163. This comprehensive scoring system helps in evaluating disease severity, aiding healthcare professionals in making informed decisions regarding patient care.\",2\n93,WILCOXON TEST,The Wilcoxon test is a non-parametric statistical test used to compare two paired groups in the study.,1\n210,TRIAL SITES,Locations where the clinical trial was conducted,1\n428,BASELINE VARIABLES,,2\n540,WILCOXON'S RANK-SUM TEST,Wilcoxon's rank-sum test is a non-parametric statistical test used in the study to compare differences between two groups,2\n624,SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE,The Sequential Organ Failure Assessment (SOFA) score is used to track a patient's status during their stay in an intensive care unit,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n308,ICU,CISATRACURIUM,Cisatracurium was administered to patients in 20 multidisciplinary ICUs following international standards of care,59\n273,PLACEBO GROUP,CISATRACURIUM,The study compares the effects of cisatracurium on 90-day mortality against a placebo group,48\n376,CISATRACURIUM,ARDS,\"Cisatracurium is a medication used in the management of patients with severe Acute Respiratory Distress Syndrome (ARDS). It has been employed in clinical trials to assess its effectiveness in improving outcomes for these patients. The trials specifically aimed to evaluate the impact of cisatracurium on 90-day mortality rates among ARDS patients. While the medication was generally used to manage ARDS, there was an instance in the trial where one death was possibly related to its use. Overall, cisatracurium's role in the treatment of ARDS is being studied to determine its potential benefits and risks.\",45\n381,CISATRACURIUM,MULTICENTER TRIAL,The multicenter trial evaluated the effectiveness of cisatracurium in treating severe ARDS,29\n383,CISATRACURIUM,INTERVENTION GROUP,Cisatracurium was administered to patients in the intervention group,21\n380,CISATRACURIUM,FISHER'S EXACT TEST,Fisher's exact test was used to assess differences between the cisatracurium and placebo groups,18\n382,CISATRACURIUM,ROSE TRIAL,Cisatracurium was used as the neuromuscular blocking agent in the ROSE trial,18\n423,EUROPEAN EPIDEMIOLOGIC STUDY,MULTICENTER TRIAL,The European epidemiologic study provided data for the sample-size calculation in the multicenter trial,18\n379,CISATRACURIUM,CHI-SQUARE TEST,The chi-square test was used to assess differences between the cisatracurium and placebo groups,17\n377,CISATRACURIUM,STUDENT'S T-TEST,Student's t-test was used to assess differences between the cisatracurium and placebo groups,17\n373,ACUTE LUNG INJURY VERIFICATION (ALIVE),CISATRACURIUM,The ALIVE study provided data for assumptions in the sample-size calculation for the cisatracurium study,15\n375,CISATRACURIUM,SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) II,SAPS II was used as a covariate in the Cox regression model to evaluate the effect of cisatracurium on 90-day mortality,15\n378,CISATRACURIUM,WILCOXON TEST,The Wilcoxon test was used to assess differences between the cisatracurium and placebo groups,14\n384,CISATRACURIUM,TRIAL SITES,Trial sites were locations where Cisatracurium was administered to patients,14\n417,CHI-SQUARE TEST,STUDY GROUP,Chi-square test was used to determine interactions between study groups and interventions,13\n415,STUDENT'S T-TEST,CHI-SQUARE TEST,Both are statistical tests used in the study to compare baseline characteristics between groups,8\n420,FISHER'S EXACT TEST,BASELINE VARIABLES,Fisher's exact test was used to compare baseline variables in the study,7\n414,STUDENT'S T-TEST,BASELINE VARIABLES,Student's t-test was used to compare baseline variables in the study,6\n418,CHI-SQUARE TEST,WILCOXON'S RANK-SUM TEST,Both are statistical tests used in the study to compare differences between groups,6\n416,STUDENT'S T-TEST,WILCOXON'S RANK-SUM TEST,Both are statistical tests used in the study to compare differences between groups,6\n374,ACUTE LUNG INJURY VERIFICATION (ALIVE),EUROPEAN EPIDEMIOLOGIC STUDY,\"The European epidemiologic study includes the Acute Lung Injury Verification (ALIVE) study, which provides data for clinical research\",4\n385,SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) II,SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE,Both the SAPS II and SOFA score were used to assess the severity of illness in patients,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}